Access to Dermatological Care with an Innovative Online Model for Psoriasis Management

Results from a Randomized Controlled Trial

Adam R. Ford, Caitlin M. Gibbons, Josefina Torres, Heather A. Kornmehl, Sanminder Singh, Paulina M. Young, Cynthia Chambers, Emanual Michael Maverakis, Cory A. Dunnick, April W. Armstrong

Research output: Contribution to journalArticle

Abstract

Background: Many patients with chronic skin diseases lack regular access to dermatologists in the United States and suffer poor clinical outcomes. Introduction: We performed a 12-month randomized controlled trial to evaluate the impact of an online, collaborative connected health (CCH) model for psoriasis management on access to specialty care. Materials and Methods: The 300 enrolled patients were randomized to online or in-person care. We compared distance traveled as well as transportation and in-office waiting time between the two groups and obtained patient and provider perspectives on CCH. Results: At baseline, no differences existed between the groups in difficulties obtaining specialty care. Over 12 months, the mean (standard deviation [SD]) distance traveled to and from appointments was 174.8 (±577.4) km/person for the in-person group and 2.2 (±14.2) km/person for the online group (p = 0.0003). The mean (SD) time spent on transportation and in-office waiting for in-person appointments was 4.0 (±4.5) h/person for the in-person group and 0.1 (±0.4) h/person for the online group (p = 0.0001). Patients found CCH to be safe, accessible, equitable, efficient, effective, and patient-centered. Providers found CCH to be useful for providing psoriasis care. Discussion: The CCH model resulted in significantly less distance traveled as well as transportation and in-office waiting time compared to in-person care. Both patients and providers were highly satisfied with CCH. Conclusions: The CCH model resulted in increased access to specialty care and enabled patient-centered, safe, and effective management of psoriasis patients.

Original languageEnglish (US)
Pages (from-to)619-627
Number of pages9
JournalTelemedicine and e-Health
Volume25
Issue number7
DOIs
StatePublished - Jul 1 2019

Fingerprint

Psoriasis
Randomized Controlled Trials
Health
Appointments and Schedules
Patient-Centered Care
Skin Diseases
Chronic Disease

Keywords

  • dermatology
  • teledermatology
  • telehealth
  • telemedicine

ASJC Scopus subject areas

  • Health Informatics
  • Health Information Management

Cite this

Ford, A. R., Gibbons, C. M., Torres, J., Kornmehl, H. A., Singh, S., Young, P. M., ... Armstrong, A. W. (2019). Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial. Telemedicine and e-Health, 25(7), 619-627. https://doi.org/10.1089/tmj.2018.0160

Access to Dermatological Care with an Innovative Online Model for Psoriasis Management : Results from a Randomized Controlled Trial. / Ford, Adam R.; Gibbons, Caitlin M.; Torres, Josefina; Kornmehl, Heather A.; Singh, Sanminder; Young, Paulina M.; Chambers, Cynthia; Maverakis, Emanual Michael; Dunnick, Cory A.; Armstrong, April W.

In: Telemedicine and e-Health, Vol. 25, No. 7, 01.07.2019, p. 619-627.

Research output: Contribution to journalArticle

Ford, AR, Gibbons, CM, Torres, J, Kornmehl, HA, Singh, S, Young, PM, Chambers, C, Maverakis, EM, Dunnick, CA & Armstrong, AW 2019, 'Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial', Telemedicine and e-Health, vol. 25, no. 7, pp. 619-627. https://doi.org/10.1089/tmj.2018.0160
Ford, Adam R. ; Gibbons, Caitlin M. ; Torres, Josefina ; Kornmehl, Heather A. ; Singh, Sanminder ; Young, Paulina M. ; Chambers, Cynthia ; Maverakis, Emanual Michael ; Dunnick, Cory A. ; Armstrong, April W. / Access to Dermatological Care with an Innovative Online Model for Psoriasis Management : Results from a Randomized Controlled Trial. In: Telemedicine and e-Health. 2019 ; Vol. 25, No. 7. pp. 619-627.
@article{398deff7fa5545b6bc730de944cf3141,
title = "Access to Dermatological Care with an Innovative Online Model for Psoriasis Management: Results from a Randomized Controlled Trial",
abstract = "Background: Many patients with chronic skin diseases lack regular access to dermatologists in the United States and suffer poor clinical outcomes. Introduction: We performed a 12-month randomized controlled trial to evaluate the impact of an online, collaborative connected health (CCH) model for psoriasis management on access to specialty care. Materials and Methods: The 300 enrolled patients were randomized to online or in-person care. We compared distance traveled as well as transportation and in-office waiting time between the two groups and obtained patient and provider perspectives on CCH. Results: At baseline, no differences existed between the groups in difficulties obtaining specialty care. Over 12 months, the mean (standard deviation [SD]) distance traveled to and from appointments was 174.8 (±577.4) km/person for the in-person group and 2.2 (±14.2) km/person for the online group (p = 0.0003). The mean (SD) time spent on transportation and in-office waiting for in-person appointments was 4.0 (±4.5) h/person for the in-person group and 0.1 (±0.4) h/person for the online group (p = 0.0001). Patients found CCH to be safe, accessible, equitable, efficient, effective, and patient-centered. Providers found CCH to be useful for providing psoriasis care. Discussion: The CCH model resulted in significantly less distance traveled as well as transportation and in-office waiting time compared to in-person care. Both patients and providers were highly satisfied with CCH. Conclusions: The CCH model resulted in increased access to specialty care and enabled patient-centered, safe, and effective management of psoriasis patients.",
keywords = "dermatology, teledermatology, telehealth, telemedicine",
author = "Ford, {Adam R.} and Gibbons, {Caitlin M.} and Josefina Torres and Kornmehl, {Heather A.} and Sanminder Singh and Young, {Paulina M.} and Cynthia Chambers and Maverakis, {Emanual Michael} and Dunnick, {Cory A.} and Armstrong, {April W.}",
year = "2019",
month = "7",
day = "1",
doi = "10.1089/tmj.2018.0160",
language = "English (US)",
volume = "25",
pages = "619--627",
journal = "Telemedicine and e-Health",
issn = "1530-5627",
publisher = "Mary Ann Liebert Inc.",
number = "7",

}

TY - JOUR

T1 - Access to Dermatological Care with an Innovative Online Model for Psoriasis Management

T2 - Results from a Randomized Controlled Trial

AU - Ford, Adam R.

AU - Gibbons, Caitlin M.

AU - Torres, Josefina

AU - Kornmehl, Heather A.

AU - Singh, Sanminder

AU - Young, Paulina M.

AU - Chambers, Cynthia

AU - Maverakis, Emanual Michael

AU - Dunnick, Cory A.

AU - Armstrong, April W.

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Background: Many patients with chronic skin diseases lack regular access to dermatologists in the United States and suffer poor clinical outcomes. Introduction: We performed a 12-month randomized controlled trial to evaluate the impact of an online, collaborative connected health (CCH) model for psoriasis management on access to specialty care. Materials and Methods: The 300 enrolled patients were randomized to online or in-person care. We compared distance traveled as well as transportation and in-office waiting time between the two groups and obtained patient and provider perspectives on CCH. Results: At baseline, no differences existed between the groups in difficulties obtaining specialty care. Over 12 months, the mean (standard deviation [SD]) distance traveled to and from appointments was 174.8 (±577.4) km/person for the in-person group and 2.2 (±14.2) km/person for the online group (p = 0.0003). The mean (SD) time spent on transportation and in-office waiting for in-person appointments was 4.0 (±4.5) h/person for the in-person group and 0.1 (±0.4) h/person for the online group (p = 0.0001). Patients found CCH to be safe, accessible, equitable, efficient, effective, and patient-centered. Providers found CCH to be useful for providing psoriasis care. Discussion: The CCH model resulted in significantly less distance traveled as well as transportation and in-office waiting time compared to in-person care. Both patients and providers were highly satisfied with CCH. Conclusions: The CCH model resulted in increased access to specialty care and enabled patient-centered, safe, and effective management of psoriasis patients.

AB - Background: Many patients with chronic skin diseases lack regular access to dermatologists in the United States and suffer poor clinical outcomes. Introduction: We performed a 12-month randomized controlled trial to evaluate the impact of an online, collaborative connected health (CCH) model for psoriasis management on access to specialty care. Materials and Methods: The 300 enrolled patients were randomized to online or in-person care. We compared distance traveled as well as transportation and in-office waiting time between the two groups and obtained patient and provider perspectives on CCH. Results: At baseline, no differences existed between the groups in difficulties obtaining specialty care. Over 12 months, the mean (standard deviation [SD]) distance traveled to and from appointments was 174.8 (±577.4) km/person for the in-person group and 2.2 (±14.2) km/person for the online group (p = 0.0003). The mean (SD) time spent on transportation and in-office waiting for in-person appointments was 4.0 (±4.5) h/person for the in-person group and 0.1 (±0.4) h/person for the online group (p = 0.0001). Patients found CCH to be safe, accessible, equitable, efficient, effective, and patient-centered. Providers found CCH to be useful for providing psoriasis care. Discussion: The CCH model resulted in significantly less distance traveled as well as transportation and in-office waiting time compared to in-person care. Both patients and providers were highly satisfied with CCH. Conclusions: The CCH model resulted in increased access to specialty care and enabled patient-centered, safe, and effective management of psoriasis patients.

KW - dermatology

KW - teledermatology

KW - telehealth

KW - telemedicine

UR - http://www.scopus.com/inward/record.url?scp=85061024659&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85061024659&partnerID=8YFLogxK

U2 - 10.1089/tmj.2018.0160

DO - 10.1089/tmj.2018.0160

M3 - Article

VL - 25

SP - 619

EP - 627

JO - Telemedicine and e-Health

JF - Telemedicine and e-Health

SN - 1530-5627

IS - 7

ER -